Sutro Biopharma (STRO) Return on Assets (2018 - 2025)

Sutro Biopharma's Return on Assets history runs 8 years deep, the most recent figure standing at 0.01% for Q4 2025.

• In Q4 2025, Return on Assets fell 1.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, down 1.0% from the prior year.
• Return on Assets came in at 0.01% for Q4 2025 at Sutro Biopharma, down from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2025 to a low of 0.01% in Q4 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets changed 0 bps in 2021 and retreated 1 bps in 2025, its largest moves.
• Sutro Biopharma's Return on Assets stood at 0.0% in 2021, then dropped by 11 bps to 0.0% in 2022, then increased by 20 bps to 0.0% in 2023, then soared by 98 bps to 0.0% in 2024, then slumped by 16349 bps to 0.01% in 2025.
• According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.0%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison